Events Search and Views Navigation
September 2013
Special Executive Briefing on NEWDIGS/Adaptive Licensing Program (regulators-only)
Session Co-Leads: Gigi Hirsch and Ken Oye (MIT)
Find out more »IOM Roundtable on Value and Science-Driven Healthcare
Regulatory Science & Practice: Overview of Adaptive Licensing.Ed Pezalla (Aetna).
Find out more »November 2013
International Conference on Rare Diseases and Orphan Drugs (ICORD)
Controlled Early Access for Medicines to Patients with High Medical Need: What Can Adaptive Licensing Offer for Patients Suffering from Rare Diseases?(Abstract submitted by Tony Hoos/GSK).
Find out more »FasterCures 5th Annual Partnering for Cures
The Art and Science of Multi-stakeholder CollaborationPanelist: Gigi Hirsch.
Find out more »Alzheimer’s Disease and Dementia Initiative
New York Academy of Sciences.Panel: Public Private Partnerships. Panelist: Gigi Hirsch
Find out more »December 2013
February 2014
21st International Molecular Medicine Tri-Conference, Leaders in Precision Medicine Symposium
“Adaptive Licensing as an Enabler for Precision Medicine”Panel: Hans-Georg Eichler (EMA), Kenneth Oye (MIT), Ed Pezalla (Aetna), Mark Trusheim (MIT), & Thomas Unger (Pfizer).
Find out more »March 2014
DIA Euro Meeting 2014
“Creating an Adaptive Pathway for Medicines to Patients–Could this Be An Approach That Fulfills the Needs of All Decision-Makers? A Roundtable Discussion.”Moderator: Andrzej Rys (European Commission, Belgium); Hans-Georg Eichler (EMA); Jurgen Windeler (IQWiG, Germany); Tomas Salmonson (CHMP/EMA); Carole Longson (NICE); Chris James (Motor Neurone Disease Association, United Kingdom); Anton Hoos (GSK).
Find out more »April 2014
Global Updates on Accelerated Access to Innovative Medicines for Patients in Need
Workshop Co-hosted by EMA, IMI, EFPIA, & MIT
Find out more »May 2014
NORD Corporate Council Meeting
“Overview of NEWDIGS-Adaptive Licensing”Thomas Unger (Pfizer).
Find out more »